Blog

Karen Knudsen: The Annual ACS Cancer Statistics Report has been released

Karen Knudsen/LinkedIn

Jan 17, 2025, 13:16

Karen Knudsen: The Annual ACS Cancer Statistics Report has been released

Karen Knudsen, the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS), shared a post on LinkedIn by American Cancer Society Journals adding:

“Hot off the press – the annual ACS Cancer Statistics Report has been released. This critical publication provides a comprehensive overview of cancer incidence and mortality trends in the U.S., offering invaluable insights into the state of cancer across the nation.

As an oncology community, we face many pressing priorities, but it’s clear from these data that prevention and early detection MUST remain at the forefront of our strategies – those efforts are essential to driving meaningful progress against the 200+ diseases collectively known as cancer.

Let’s continue to collaborate and innovate to save lives and reduce the burden of cancer for individuals and families everywhere.”

Quoting American Cancer Society Journals’s post below:

“The 2025 American Cancer Society Cancer Statistics report, published today in CA: A Cancer Journal for Clinicians, provides the latest insights into cancer incidence, mortality, and disparities in the United States.

Key findings:

A 34% decline in cancer mortality since 1991 has averted approximately 4.5 million deaths.
Rising cancer incidence among women and younger adults is shifting the cancer burden.
Stark disparities persist, with cancer mortality rates 2-3 times higher in some racial and ethnic groups.

The authors emphasize the importance of sustained efforts in cancer prevention, research, and equitable access to care.

Access the full report, available for free in CA.”

Karen E. Knudsen is the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute, on 12 external advisory boards for NCI-designated cancer centers and on Exai Bio. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.